Prevalence of klebsiella pneumoniae encoding genes for Ctx-M-1, tem-1 and shv-1 extended-spectrum beta lactamases (ESBL) enzymes in clinical specimens

Jundishapur Journal of Microbiology

Volumn 6, Issue 10, 2013, Pages

  Khosravi, Azar Dokht ^a   Hoveizavi, Hajar ^a   Mehdinejad, Manijeh ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic; Beta lactamases; K. penumoniae; Polymerase chain reaction

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CTX M 1 GENE; DISK DIFFUSION; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; NONHUMAN; SHV 1 GENE; TEM 1 GENE;

EID: 84891517651     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.8256     Document Type: Article

References (39)

1. Oteo J, Cuevas O, Lopez-Rodriguez I, Banderas-Florido A, Vindel A, Perez-Vazquez M, et al. Emergence of CTX-M-15-producing Kleb-siella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother. 2009;64(3):524-8.
2. Herwana E, Pudjiadi YL, Surjawidjaja JE, Lesmana M. Prevalence of extended spectrum beta-lactamase in Klebsiella pneumonia. Univ Med. 2008;27:98-105.
3. Fankhauser C, Zingg W, Francois P, Dharan S, Schrenzel J, Pittet D, et al. Surveillance of extended-spectrum-beta-lactamase-produc-ing Enterobacteriaceae in a Swiss Tertiary Care Hospital. Swiss Med Wkly. 2009;139(51-52):747-51.
4. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother. 2004;48(12):4574-81.
5. Lin CF, Hsu SK, Chen CH, Huang JR, Lo HH. Genotypic detection and molecular epidemiology of extended-spectrum beta-lacta-mase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Med Microbiol. 2010;59(Pt 6):665-71.
6. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56(1):52-9.
7. French GL, Shannon KP, Simmons N. Hospital outbreak of Kleb-siella pneumoniae resistant to broad-spectrum cephalospo-rins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase. J Clin Microbiol. 1996;34(2):358-63.
8. Lin TL, Tang SI, Fang CT, Hsueh PR, Chang SC, Wang JT. Extended-spectrum beta-lactamase genes of Klebsiella pneumoniae strains in Taiwan: recharacterization of shv-27, shv-41, and tem-116. Microb Drug Resist. 2006;12(1):12-5.
9. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
10. Pfaller MA, Segreti J. Overview of the epidemiological profle and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis. 2006;42 Suppl 4:S153-63.
11. Walther-Rasmussen J, Hoiby N. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases. Can J Microbiol. 2004;50(3):137-65.
12. Soge OO, Queenan AM, Ojo KK, Adeniyi BA, Roberts MC. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae. J Antimicrob Chemother. 2006;57(1):24-30.
13. Doi Y, Adams-Haduch JM, Shivannavar CT, Paterson DL, Gaddad SM. Faecal carriage of CTX-M-15-producing Klebsiella pneu-moniae in patients with acute gastroenteritis. Indian J Med Res. 2009;129(5):599-602.
14. Kim J, Lim YM. Prevalence Of CTX-M extended-spectrum beta-lactamases in clinical isolates of Entrobacteriaceae in Korea. J Bacteriol Virol. 2004;34:303-10.
15. Baby Padmini S, Appala Raju B, Mani KR. Detection of Enterobac-teriaceae producing CTX-M extended spectrum beta-lactamases from a tertiary care hospital in south India. Indian J Med Micro-biol. 2008;26(2):163-6.
16. Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 12 edSt. Louis: Mosby Inc.; 2007.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Pennsylvania, USA: 12th Informational Supplement; 2002.
18. Naseer U, Natas OB, Haldorsen BC, Bue B, Grundt H, Walsh TR, et al. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS. 2007;115(2):120-6.
19. Dashti AA, Jadaon MM, Gomaa HH, Noronha B, Udo EE. Transmission of a Klebsiella pneumoniae clone harbouring genes for CTX-M-15-like and SHV-112 enzymes in a neonatal intensive care unit of a Kuwaiti hospital. J Med Microbiol. 2010;59(Pt 6):687-92.
20. Raveh D, Yinnon AM, Broide E, Rudensky B. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid. Chemotherapy. 2007;53(3):185-9.
21. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shaban-poor S, Bokaei S. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsi-ella pneumoniae in Tehran. Med Sci Monit. 2006;12(11):BR362-5.
22. Mehrgan H, Rahbar M, Arab-Halvaii Z. High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries. 2010;4(3):132-8.
23. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933-51.
24. Avci IY, Kilic S, Acikel CH, Ucar M, Hasde M, Eyigun CP, et al. Outpatient prescription of oral antibiotics in a training hospital in Turkey: trends in the last decade. J Infect. 2006;52(1):9-14.
25. Loh LC, Chin HK, Chong YY, Jeyaratnam A, Raman S, Vijayasing-ham P, et al. Klebsiella pneumoniae respiratory isolates from 2000 to 2004 in a Malaysian hospital: characteristics and relation to hospital antibiotics consumption. Singapore Med J. 2007;48(9):813-8.
26. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacifc region. Clin Infect Dis. 2001;32 Suppl 2:S94-103.
27. Kader AA, Kumar A. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med. 2005;25(3):239-42.
28. Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, et al. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents. 2004;24(2):119-24.
29. Daoud Z, Hakime N. Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Rev Esp Quimioter. 2003;16(2):233-8.
30. Yaman A, Tasova Y, Kibar F, Inal AS, Saltoglu N, Buyukcelik O, et al. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections. Saudi Med J. 2004;25(10):1403-9.
31. Shehabi AA, Mahafzah A, Baadran I, Qadar FA, Dajani N. High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units. Diagn Microbiol Infect Dis. 2000;36(1):53-6.
32. Jabeen K, Zafar A, Hasan R. Frequency and sensitivity pattern of Extended Spectrum beta Lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Assoc. 2005;55(10):436-9.
33. Feizabadi MM, Mahamadi-Yeganeh S, Mirsalehian A, Mirafshar SM, Mahboobi M, Nili F, et al. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J Infect Dev Ctries. 2010;4(10):609-15.
34. Aminzadeh Z, Sadat Kashi M, Sha'bani M. Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iran J Kidney Dis. 2008;2(4):197-200.
35. Behrooozi A, Rahbar M, Yousef JV. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and klebseilla pneumonia isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res. 2010;4:881-4.
36. Irajian G, Jazayeri-Moghadas A, Beheshti A. Prevalence of extended-spectrum beta lactamase positive and multidrug resistance pattern of Escherichia coli and Klebsiella pneumoniae isolates, Semnan, Iran. Iran J Microbiol. 2009;1:49-53.
37. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoni-ae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008;52(8):2818-24.
38. Eftekhar F, Rastegar M, Golalipoor M, Mansoursamaei N. Detection of Extended Spectrum B-Lactamases in Urinary Isolates of Klebsiella pneumoniae in Relation to Bla, Bla and Bla Gene Carriage. Iran J Public Health. 2012;41(3):127-32.
39. Moosavian M, Deiham B. Distribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran. Afr J Microbiol Res. 2012;6:5433-9.